Nasdaq Pxmd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TARRYTOWN, N.Y. , Oct. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD) a clinical-stage biopharmaceutical company, is excited to...

LOS ANGELES, Oct. 18, 2023 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the...

PaxMedica (NASDAQ:PXMD – Get Free Report) is one of 952 public companies in the “Pharmaceutical preparations” industry, but how does it compare to its peers? We will compare PaxMedica to similar businesses based on the strength of its institutional ownership, risk, earnings, valuation, dividends, analyst recommendations and profitability. Profitability This table compares PaxMedica and its […]

PaxMedica, Inc. (NASDAQ:PXMD – Get Free Report) was the target of a large drop in short interest in June. As of June 30th, there was short interest totalling 240,700 shares, a drop of 28.7% from the June 15th total of 337,700 shares. Based on an average trading volume of 340,900 shares, the days-to-cover ratio is […]

PaxMedica (NASDAQ:PXMD – Get Free Report) is one of 975 public companies in the “Pharmaceutical preparations” industry, but how does it contrast to its peers? We will compare PaxMedica to related companies based on the strength of its institutional ownership, valuation, risk, dividends, earnings, profitability and analyst recommendations. Earnings and Valuation This table compares PaxMedica […]